Canada · Delayed Price · Currency is CAD Profound Medical Statistics
Total Valuation
TSX:PRN has a market cap or net worth of CAD 284.42 million. The enterprise value is 256.47 million.
| Market Cap | 284.42M |
| Enterprise Value | 256.47M |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:PRN has 30.19 million shares outstanding. The number of shares has increased by 22.70% in one year.
| Current Share Class | 30.19M |
| Shares Outstanding | 30.19M |
| Shares Change (YoY) | +22.70% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 8.37% |
| Owned by Institutions (%) | 46.99% |
| Float | 27.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.28 |
| PB Ratio | 6.35 |
| P/TBV Ratio | 6.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.68 |
| EV / Sales | 12.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.15.
| Current Ratio | 4.18 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -217.68 |
Financial Efficiency
Return on equity (ROE) is -124.49% and return on invested capital (ROIC) is -71.15%.
| Return on Equity (ROE) | -124.49% |
| Return on Assets (ROA) | -62.44% |
| Return on Invested Capital (ROIC) | -71.15% |
| Return on Capital Employed (ROCE) | -130.47% |
| Revenue Per Employee | 140,240 |
| Profits Per Employee | -385,909 |
| Employee Count | 142 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.53 |
Taxes
| Income Tax | -16,715 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.19% in the last 52 weeks. The beta is 0.19, so TSX:PRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -16.19% |
| 50-Day Moving Average | 7.50 |
| 200-Day Moving Average | 7.86 |
| Relative Strength Index (RSI) | 69.94 |
| Average Volume (20 Days) | 18,548 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:PRN had revenue of CAD 19.91 million and -54.80 million in losses. Loss per share was -1.89.
| Revenue | 19.91M |
| Gross Profit | 14.44M |
| Operating Income | -58.82M |
| Pretax Income | -54.82M |
| Net Income | -54.80M |
| EBITDA | -57.86M |
| EBIT | -58.82M |
| Loss Per Share | -1.89 |
Balance Sheet
The company has 34.58 million in cash and 6.63 million in debt, giving a net cash position of 27.95 million or 0.93 per share.
| Cash & Cash Equivalents | 34.58M |
| Total Debt | 6.63M |
| Net Cash | 27.95M |
| Net Cash Per Share | 0.93 |
| Equity (Book Value) | 44.77M |
| Book Value Per Share | 1.48 |
| Working Capital | 44.00M |
Cash Flow
| Operating Cash Flow | -52.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 72.49%, with operating and profit margins of -295.38% and -275.18%.
| Gross Margin | 72.49% |
| Operating Margin | -295.38% |
| Pretax Margin | -275.26% |
| Profit Margin | -275.18% |
| EBITDA Margin | -290.56% |
| EBIT Margin | -295.38% |
| FCF Margin | n/a |
Dividends & Yields
TSX:PRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.70% |
| Shareholder Yield | -22.70% |
| Earnings Yield | -19.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 16, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |